85 related articles for article (PubMed ID: 25744667)
1. Recent trends in type-specific HPV infection rates in the United States.
Dickson EL; Vogel RI; Luo X; Downs LS
Epidemiol Infect; 2015 Apr; 143(5):1042-7. PubMed ID: 25744667
[TBL] [Abstract][Full Text] [Related]
2. Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening.
Ralston Howe E; Li Z; McGlennen RC; Hellerstedt WL; Downs LS
Am J Obstet Gynecol; 2009 Mar; 200(3):245.e1-7. PubMed ID: 19254582
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
6. Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women.
Baay MF; Smits E; Tjalma WA; Lardon F; Weyler J; Van Royen P; Van Marck EA; Vermorken JB
Int J Cancer; 2004 Jan; 108(2):258-61. PubMed ID: 14639612
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
8. Cervical human papillomavirus screening among older women.
Grainge MJ; Seth R; Guo L; Neal KR; Coupland C; Vryenhoef P; Johnson J; Jenkins D
Emerg Infect Dis; 2005 Nov; 11(11):1680-5. PubMed ID: 16318718
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes of the cervix influence human papillomavirus type distribution.
Castle PE; Jeronimo J; Schiffman M; Herrero R; Rodríguez AC; Bratti MC; Hildesheim A; Wacholder S; Long LR; Neve L; Pfeiffer R; Burk RD
Cancer Res; 2006 Jan; 66(2):1218-24. PubMed ID: 16424061
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study.
Agorastos T; Chatzistamatiou K; Zafrakas M; Siamanta V; Katsamagkas T; Constantinidis TC; Lampropoulos AF;
Eur J Cancer Prev; 2014 Sep; 23(5):425-31. PubMed ID: 24977385
[TBL] [Abstract][Full Text] [Related]
11. Are women with lupus at higher risk of HPV infection?
Klumb EM; Pinto AC; Jesus GR; Araujo M; Jascone L; Gayer CR; Ribeiro FM; Albuquerque EM; Macedo JM
Lupus; 2010 Nov; 19(13):1485-91. PubMed ID: 20605875
[TBL] [Abstract][Full Text] [Related]
12. Type-specific prevalence of Human Papillomavirus infection among women in the Northwest Territories, Canada.
Jiang Y; Brassard P; Severini A; Goleski V; Santos M; Leamon A; Chatwood S; Lys C; Johnson G; Wong T; Kotaska A; Kandola K; Mao Y
J Infect Public Health; 2011 Nov; 4(5-6):219-27. PubMed ID: 22118716
[TBL] [Abstract][Full Text] [Related]
13. Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study.
Carozzi F; Ronco G; Gillio-Tos A; De Marco L; Del Mistro A; Girlando S; Franceschi S; Plummer M; Vaccarella S;
Eur J Cancer; 2012 Jul; 48(11):1633-7. PubMed ID: 22088483
[TBL] [Abstract][Full Text] [Related]
14. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women.
Nielsen A; Kjaer SK; Munk C; Iftner T
Sex Transm Dis; 2008 Mar; 35(3):276-82. PubMed ID: 18091564
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes.
Beerens E; Van Renterghem L; Praet M; Sturtewagen Y; Weyers S; Temmerman M; Depypere H; Claeys P; Cuvelier CA
Cytopathology; 2005 Aug; 16(4):199-205. PubMed ID: 16048506
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus prevalence at the USA-Mexico border among women 40 years of age and older.
Giuliano AR; Papenfuss MR; Denman CA; de Zapien JG; Abrahamsen M; Hunter JB
Int J STD AIDS; 2005 Mar; 16(3):247-51. PubMed ID: 15829027
[TBL] [Abstract][Full Text] [Related]
17. [Study on subtype of human papillomavirus infection among aged 25 - 54 reproductive women in Beijing from 2006 to 2008].
Zhao R; Zhang WY; Zhang SW; Wu MH; Wang JD; Xie Z; Feng J; Pan J; Wang JH; Liu XZ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):184-7. PubMed ID: 21575451
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group.
Sellors JW; Mahony JB; Kaczorowski J; Lytwyn A; Bangura H; Chong S; Lorincz A; Dalby DM; Janjusevic V; Keller JL
CMAJ; 2000 Sep; 163(5):503-8. PubMed ID: 11006760
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type-specific prevalence in women referred for colposcopic examination in Beijing.
Ding X; Liu Z; Su J; Yan D; Sun W; Zeng Z
J Med Virol; 2014 Nov; 86(11):1937-43. PubMed ID: 25132373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
